The Effects Of Sitaxsentan Once Daily Dosing On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Subjects With Chronic Kidney Disease.

Trial Profile

The Effects Of Sitaxsentan Once Daily Dosing On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Subjects With Chronic Kidney Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2014

At a glance

  • Drugs Sitaxentan (Primary) ; Nifedipine
  • Indications Kidney disorders
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 12 May 2014 New trial record
    • 19 May 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top